TransMedics Group Statistics
Total Valuation
TMDX has a market cap or net worth of $3.07 billion. The enterprise value is $3.47 billion.
| Market Cap | 3.07B |
| Enterprise Value | 3.47B |
Important Dates
The last earnings date was Tuesday, August 4, 2026, after market close.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TMDX has 34.68 million shares outstanding. The number of shares has increased by 1.53% in one year.
| Current Share Class | 34.68M |
| Shares Outstanding | 34.68M |
| Shares Change (YoY) | +1.53% |
| Shares Change (QoQ) | +12.48% |
| Owned by Insiders (%) | 3.23% |
| Owned by Institutions (%) | 102.16% |
| Float | 33.54M |
Valuation Ratios
The trailing PE ratio is 22.07 and the forward PE ratio is 47.49.
| PE Ratio | 22.07 |
| Forward PE | 47.49 |
| PS Ratio | 4.59 |
| Forward PS | 3.81 |
| PB Ratio | 5.92 |
| P/TBV Ratio | 6.06 |
| P/FCF Ratio | 38.86 |
| P/OCF Ratio | 21.05 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 29.98, with an EV/FCF ratio of 43.86.
| EV / Earnings | 22.85 |
| EV / Sales | 5.19 |
| EV / EBITDA | 29.98 |
| EV / EBIT | 42.48 |
| EV / FCF | 43.86 |
Financial Position
The company has a current ratio of 6.62, with a Debt / Equity ratio of 1.67.
| Current Ratio | 6.62 |
| Quick Ratio | 5.87 |
| Debt / Equity | 1.67 |
| Debt / EBITDA | 6.99 |
| Debt / FCF | 10.98 |
| Interest Coverage | 3.84 |
Financial Efficiency
Return on equity (ROE) is 36.28% and return on invested capital (ROIC) is 9.02%.
| Return on Equity (ROE) | 36.28% |
| Return on Assets (ROA) | 4.33% |
| Return on Invested Capital (ROIC) | 9.02% |
| Return on Capital Employed (ROCE) | 5.97% |
| Weighted Average Cost of Capital (WACC) | 11.80% |
| Revenue Per Employee | $744,396 |
| Profits Per Employee | $168,930 |
| Employee Count | 898 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 5.46 |
Taxes
| Income Tax | -79.15M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -32.91% in the last 52 weeks. The beta is 1.88, so TMDX's price volatility has been higher than the market average.
| Beta (5Y) | 1.88 |
| 52-Week Price Change | -32.91% |
| 50-Day Moving Average | 75.52 |
| 200-Day Moving Average | 107.30 |
| Relative Strength Index (RSI) | 65.02 |
| Average Volume (20 Days) | 1,025,975 |
Short Selling Information
The latest short interest is 7.67 million, so 22.13% of the outstanding shares have been sold short.
| Short Interest | 7.67M |
| Short Previous Month | 7.72M |
| Short % of Shares Out | 22.13% |
| Short % of Float | 22.87% |
| Short Ratio (days to cover) | 9.08 |
Income Statement
In the last 12 months, TMDX had revenue of $668.47 million and earned $151.70 million in profits. Earnings per share was $4.01.
| Revenue | 668.47M |
| Gross Profit | 392.35M |
| Operating Income | 81.61M |
| Pretax Income | 72.55M |
| Net Income | 151.70M |
| EBITDA | 115.63M |
| EBIT | 81.61M |
| Earnings Per Share (EPS) | $4.01 |
Balance Sheet
The company has $472.68 million in cash and $867.72 million in debt, with a net cash position of -$395.05 million or -$11.39 per share.
| Cash & Cash Equivalents | 472.68M |
| Total Debt | 867.72M |
| Net Cash | -395.05M |
| Net Cash Per Share | -$11.39 |
| Equity (Book Value) | 518.05M |
| Book Value Per Share | 14.96 |
| Working Capital | 552.84M |
Cash Flow
In the last 12 months, operating cash flow was $145.93 million and capital expenditures -$66.89 million, giving a free cash flow of $79.04 million.
| Operating Cash Flow | 145.93M |
| Capital Expenditures | -66.89M |
| Depreciation & Amortization | 34.02M |
| Net Borrowing | n/a |
| Free Cash Flow | 79.04M |
| FCF Per Share | $2.28 |
Margins
Gross margin is 58.69%, with operating and profit margins of 12.21% and 22.69%.
| Gross Margin | 58.69% |
| Operating Margin | 12.21% |
| Pretax Margin | 10.85% |
| Profit Margin | 22.69% |
| EBITDA Margin | 17.30% |
| EBIT Margin | 12.21% |
| FCF Margin | 11.82% |
Dividends & Yields
TMDX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.53% |
| Shareholder Yield | -1.53% |
| Earnings Yield | 4.94% |
| FCF Yield | 2.57% |
Analyst Forecast
The average price target for TMDX is $97.30, which is 9.84% higher than the current price. The consensus rating is "Buy".
| Price Target | $97.30 |
| Price Target Difference | 9.84% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 18.82% |
| EPS Growth Forecast (3Y) | 7.91% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TMDX has an Altman Z-Score of 3.33 and a Piotroski F-Score of 4.
| Altman Z-Score | 3.33 |
| Piotroski F-Score | 4 |